Respiratory Inhaler Devices Market Worth US$ 43,214.0 Mn by 2025 : GlaxoSmithKline Plc, Cipla Ltd., Koninklijke Philips N.V., PARI Medical Holding
Increase in usage of combination therapies such as triple combination therapy for COPD patients is expected to drive growth of the global respiratory inhaler devices market over the forecast period.
View full press release